Skip to content

Opening book details…

Can I read Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients on EtoBox?

Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients by Cheng-Wen Yang; Mei-Chen Lin; Kai-Hsiang Shu; Kuei-Tung Tung; Wan-Chuan Tsai; Ju-Yeh Yang; Mei-Fen Pai; Hon-Yen Wu; Yen-Ling Chiu; Yu-Sen Peng; Shih-Ping Hsu; Shi-Heng Wang; Szu-Yu Pan is a Medicine article available to read on EtoBox.

What is Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients about?

Introduction: Although high-dose erythropoiesis-stimulating agent (ESA) has been shown to increase mortality risk and adverse cardiovascular events in hemodialysis patients, the safety of extremely low-dose ESA is unclear. Methods: We retrospectively analyzed the association between ESA dose and mortality in the monthly dosing range of 0–43,000 U of equivalent epoetin alfa in 304 Taiwan hemodialysis patients by using Cox proportional hazard model and cubic spline model. Results: Compared with mean monthly ESA dose of 15,000–25,000 U (mean ± standard deviation 20,609 ± 2,662 U), monthly ESA dose of less than 15,000 U (mean ± standard deviation 7,413 ± 4,510 U) is associated with increased mortality. Monthly ESA dose of 25,001–43,000 U (mean ± standard deviation 31,160 ± 4,304 U) is not associated with higher mortality risk than monthly ESA dose of 15,000–25,000 U. The results were consistent in Cox proportional hazard models and cubic spline models. Subgroup analyses showed no significant heterogeneities among prespecified subgroups. Conclusions: Extremely low dose of ESA in hemodialysis patients may be associated with increased mortality risk. Future studies are warranted to prove

Who reads Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Cheng-Wen Yang; Mei-Chen Lin; Kai-Hsiang Shu; Kuei-Tung Tung; Wan-Chuan Tsai; Ju-Yeh Yang; Mei-Fen Pai; Hon-Yen Wu; Yen-Ling Chiu; Yu-Sen Peng; Shih-Ping Hsu; Shi-Heng Wang; Szu-Yu Pan
Publisher
S. Karger AG
Published
2023
Language
EN
Field
Medicine (Health Sciences)

More by Cheng-Wen Yang; Mei-Chen Lin; Kai-Hsiang Shu; Kuei-Tung Tung; Wan-Chuan Tsai; Ju-Yeh Yang; Mei-Fen Pai; Hon-Yen Wu; Yen-Ling Chiu; Yu-Sen Peng; Shih-Ping Hsu; Shi-Heng Wang; Szu-Yu Pan

Browse all works by Cheng-Wen Yang; Mei-Chen Lin; Kai-Hsiang Shu; Kuei-Tung Tung; Wan-Chuan Tsai; Ju-Yeh Yang; Mei-Fen Pai; Hon-Yen Wu; Yen-Ling Chiu; Yu-Sen Peng; Shih-Ping Hsu; Shi-Heng Wang; Szu-Yu Pan